Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Write summary.Osteoporosis is misdiagnosed more often than many people expect, with studies suggesting that a large share of cases go undetected until a fracture occurs, while others are labeled osteoporosis when the real cause is a different bone or metabolic condition. Underdiagnosis is especially common in men, younger adults, and people whose bone loss is driven by medications, vitamin D deficiency, hyperparathyroidism, or cancer. Overdiagnosis can also happen when bone density scans are misread, when scan sites are affected by arthritis or prior surgery, or when results are not matched to fracture risk. Several factors influence how accurate a diagnosis will be, including scan technique, lab testing, and whether secondary causes were ruled out. See below to understand more about the details that can change your diagnosis and treatment plan.
If you are dealing with unexplained bone pain, height loss, fractures from minor falls, or uncertainty about a recent scan result, guessing is the riskiest option. A free, instant, online symptom check can help you organize your symptoms, surface possibilities you may not have considered, and clarify which questions and tests to raise with a clinician. It takes only a few minutes, requires no appointment, and gives you a clearer starting point for your next steps.
Last reviewed for medical accuracy: 08/18/2026
Osteoporosis—characterized by low bone density and increased fracture risk—affects millions worldwide. Early and accurate diagnosis is crucial to prevent fractures, disability, and reduced quality of life. Yet errors in testing and interpretation mean osteoporosis misdiagnosis remains a real concern. Below, we explore how often it happens, why it occurs, and what you can do to protect your bone health.
Osteoporosis misdiagnosis falls into two broad categories:
• False negatives: Someone with low bone density is told their bones are normal, delaying treatment.
• False positives: Someone with normal bone density is labeled osteoporotic, leading to unnecessary anxiety and treatment.
Both scenarios carry risks—missed prevention in one, overtreatment in the other.
While exact rates vary by setting and patient population, research highlights significant gaps:
• Missed vertebral fractures on routine spinal X-rays occur in up to 50% of cases.¹
• Among postmenopausal women screened by DXA (dual-energy X-ray absorptiometry), studies suggest 5–10% may be misclassified due to machine or operator variability.²
• Men are diagnosed far less often; one large registry found up to 80% of men with fragility fractures had never had their bone density measured, effectively a false-negative screening rate.³
In sum, osteoporosis misdiagnosis—whether by oversight or technical error—could affect tens of thousands of adults each year in the U.S. alone.
Technical and operator issues
Interpretation variability
Incomplete risk assessment
Gender and age biases
False negatives
• Delay in preventive therapies (bisphosphonates, supplements, lifestyle changes)
• Higher risk of hip, spine or wrist fractures—potentially life-threatening in older adults
False positives
• Unnecessary medication costs and side effects (jaw pain, gastrointestinal upset)
• Emotional distress from an incorrect “serious disease” label
Health systems and providers can lower error rates by:
• Standardizing DXA protocols
– Regular machine calibration and quality control
– Training and certification for technicians (International Society for Clinical Densitometry guidelines)
• Incorporating fracture assessment
– Use vertebral fracture assessment (VFA) alongside DXA in high-risk patients
– Cross-check radiology reports specifically for compression fractures
• Using comprehensive risk tools
– Apply FRAX® or Garvan calculators to integrate clinical risk factors
– Avoid reliance on bone density alone
• Expanding screening criteria
– Include men over age 70 or after any low-trauma fracture
– Evaluate younger postmenopausal women with multiple risk factors
You play a key role in ensuring an accurate diagnosis:
• Know your risk factors
– Family history of osteoporosis or hip fracture
– Early menopause or prolonged steroid use
– Smoking, excessive alcohol, low body weight
• Ask about testing details
– Confirm the facility follows up-to-date DXA procedures
– Inquire whether vertebral fracture assessment is included if you’ve had back pain or height loss
• Seek a second opinion
– If you’re told your bone density is normal but have risk factors, consider repeat testing or additional imaging.
– If diagnosed with osteoporosis, review your results and treatment plan with a bone specialist.
• Monitor your symptoms
– Unexplained back pain, loss of height or a “stooped” posture can signal vertebral fractures.
– Recognize that osteoporosis is often “silent” until a fracture occurs.
Wondering if your symptoms or risk factors warrant further evaluation? Try a free, online symptom check, using the doctor approved Ubie Symptom Checker. It’s a quick way to gather insights before you talk with your doctor.
If you experience sudden back pain, a recent low-trauma fracture, or any symptom that feels serious, speak to a doctor promptly. Only a healthcare professional can interpret bone density tests in the context of your overall health and recommend the right prevention or treatment plan.
• Osteoporosis misdiagnosis—both false negatives and positives—remains common, affecting up to half of patients with vertebral fractures and significant portions of DXA screenings.
• Technical issues, interpretation variability, incomplete risk assessment and screening biases all contribute.
• Accurate diagnosis prevents fractures and avoids unnecessary treatments.
• You can improve your chances by understanding your risk, asking detailed questions about testing, and using tools like FRAX® and symptom checkers.
Early detection is your best defense. If you have risk factors or unexplained symptoms, don’t hesitate to discuss bone health with your healthcare provider—your future self will thank you.
¹ Genant HK, et al. Radiology. 1993;187(1):45–54.
² Shepherd JA, et al. J Clin Densitom. 2015;18(3):388–395.
³ Barcenilla-Wong N, et al. Osteoporos Int. 2017;28(4):1267–1276.
(References)
* Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993 Sep;8(9):1137-48. doi: 10.1002/jbmr.5650080915. PMID: 8237484.
* Chesnut CH 3rd. Osteoporosis, an underdiagnosed disease. JAMA. 2001 Dec 12;286(22):2865-6. doi: 10.1001/jama.286.22.2865. PMID: 11735763.
* Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 2002 Jun 1;359(9321):1929-36. doi: 10.1016/S0140-6736(02)08761-5. PMID: 12057569.
* Bassil N. Late-onset hypogonadism. Med Clin North Am. 2011 May;95(3):507-23, x. doi: 10.1016/j.mcna.2011.03.001. PMID: 21549875.
* Pickhardt PJ, Pooler BD, Lauder T, del Rio AM, Bruce RJ, Binkley N. Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications. Ann Intern Med. 2013 Apr 16;158(8):588-95. doi: 10.7326/0003-4819-158-8-201304160-00003. PMID: 23588747; PMCID: PMC3736840.
* Bandeira L, Silva BC, Bilezikian JP. Male osteoporosis. Arch Endocrinol Metab. 2022 Nov 11;66(5):739-747. doi: 10.20945/2359-3997000000563. PMID: 36382763; PMCID: PMC10118818.
* Anderson PA, Binkley NC, Bernatz JT. Bone Health Optimization (BHO) in Spine Surgery. Spine (Phila Pa 1976). 2023 Jun 1;48(11):782-790. doi: 10.1097/BRS.0000000000004618. Epub 2023 Mar 13. PMID: 36917718.
* Martiniakova M, Biro R, Penzes N, Sarocka A, Kovacova V, Mondockova V, Omelka R. Links among Obesity, Type 2 Diabetes Mellitus, and Osteoporosis: Bone as a Target. Int J Mol Sci. 2024 Apr 28;25(9). doi: 10.3390/ijms25094827. Epub 2024 Apr 28. PMID: 38732046; PMCID: PMC11084398.
* Huang CF, Ho CJ, Lin SY, Hwang JS, Tai TW, Chen JF, Tu ST, Chan DC, Yang RS, Chen HY, Tsai KS, Cheng TT, Chen FP, Hung WC, Chang YF, Han DS, Chandran M, Bin AS, Lee JK, Yeap SS, Chung YS, Kim KK, Ebeling P, Jaisamrarn U, Pandey D, Ferrari S, McCloskey E, Charatcharoenwitthaya N, Taguchi A, Lekamwasam S, Van Nguyen T, Lewiecki EM, Saag KG, Tsai CC, Marín F, Mori S, Hwang KR, Li-Yu J, Carey JJ, Kendler D, Cheung CL, Huang HK, Kuptniratsaikul V, Chan WP, Chan SP, Ho-Pham LT, Hew FL, Shi H, Reid I, Kanis JA, Chen CH, Wu CH. Asia-Pacific consensus for the management of osteoporosis in men. Osteoporos Int. 2025 Jul;36(7):1105-1114. doi: 10.1007/s00198-025-07559-1. Epub 2025 Jun 4. PMID: 40464984; PMCID: PMC12209010.
* Yi YT, Zhao HF, Wang WZ, Li X. Osteosarcopenia: epidemiology, molecular mechanisms, and management. Front Endocrinol (Lausanne). 2025;16:1577758. doi: 10.3389/fendo.2025.1577758. Epub 2025 Aug 28. PMID: 40951438; PMCID: PMC12422917.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.